SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alexander Bury, Ilse S. Pienaar, Behavioral testing regimens in genetic-based animal models of Parkinson's disease: Cogencies and caveats, Neuroscience & Biobehavioral Reviews, 2013, 37, 5, 846

    CrossRef

  2. 2
    Tomohiro Omura, Masayuki Kaneko, Yasunobu Okuma, Kazuo Matsubara, Yasuyuki Nomura, Endoplasmic Reticulum Stress and Parkinson’s Disease: The Role of HRD1 in Averting Apoptosis in Neurodegenerative Disease, Oxidative Medicine and Cellular Longevity, 2013, 2013, 1

    CrossRef

  3. 3
    Christina Sundal, Shinsuke Fujioka, Ryan J. Uitti, Zbigniew K. Wszolek, Autosomal dominant Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S7

    CrossRef

  4. 4
    Isobel J. Sleeman, Eugene L. Boshoff, Susan Duty, Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease, Neuropharmacology, 2012, 63, 7, 1268

    CrossRef

  5. 5
    C.-L. Huang, Y.-H. Wu-Chou, S.-C. Lai, H.-C. Chang, T.-H. Yeh, Y.-H. Weng, R.-S. Chen, Y.-Z. Huang, C.-S. Lu, Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson’s disease in Taiwan, European Journal of Neurology, 2011, 18, 10
  6. 6
    Silvia A. Mandel, Micaela Morelli, Ilan Halperin, Amos D. Korczyn, Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy, The EPMA Journal, 2010, 1, 2, 273

    CrossRef

  7. 7
    L. Defebvre, Maladie de Parkinson : rôle des facteurs génétiques et environnementaux. Implication en pratique clinique quotidienne, Revue Neurologique, 2010, 166, 10, 764

    CrossRef

  8. 8
    Martin Stöckl, Bart D. van Rooijen, Mireille M. A. E. Claessens, Vinod Subramaniam, Structural and Functional Insights into α-Synuclein–Lipid Interactions,